Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 46
Item hits:
Issue DateTitleAuthor(s)
1-Nov-2014FOXM1: An emerging master regulator of DNA damage response and genotoxic agent resistance.Zona, S; Bella, L; Burton, MJ; Nestal de Moraes, G; Lam, EW
24-Sep-2015FOXA1 repression is associated with loss of BRCA1 and increased promoter methylation and chromatin silencing in breast cancer.Gong, C; Fujino, K; Monteiro, LJ; Gomes, AR; Drost, R, et al
11-May-2015Paclitaxel targets FOXM1 to regulate KIF20A in mitotic catastrophe and breast cancer paclitaxel resistance.Khongkow, P; Gomes, AR; Gong, C; Man, EP; Tsang, JW, et al
16-Sep-2015FOXO3a and Post-translational Modifications Mediate Glucocorticoid Sensitivity in Acute B-ALLConsolaro, F; Ghaem-Maghami, S; Bortolozzi, R; Zona, S; Khongkow, M, et al
19-Jan-2016Nuclear AURKA acquires kinase-independent transactivating function to enhance breast cancer stem cell phenotype.Zheng, F; Yue, C; Li, G; He, B; Cheng, W, et al
7-Sep-2015Forkhead box K2 modulates epirubicin and paclitaxel sensitivity through FOXO3a in breast cancerLam, EW
1-May-2010Silencing of the JNK pathway maintains progesterone receptor activity in decidualizing human endometrial stromal cells exposed to oxidative stress signalsLeitao, B; Jones, MC; Fusi, L; Higham, J; Lee, Y, et al
27-Jun-2016p62/SQSTM1 enhances breast cancer stem-like properties by stabilizing MYC mRNAXu, LZ; Li, SS; Zhou, W; Kang, ZJ; Zhang, QX, et al
4-Apr-2016BRCA1 positively regulates FOXO3 expression by restricting FOXO3 gene methylation and epigenetic silencing through targeting EZH2 in breast cancerLam, EW; Gong, C; Yao, S; Gomes, AR; , et al
11-Jan-2017Unravelling the role of fatty acid metabolism in cancer through the FOXO3-FOXM1 axis.Saavedra-GarcĂ­a, P; Nichols, K; Mahmud, Z; Fan, LY; Lam, EW